{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:26Z","timestamp":1791475346947,"version":"4.3.4"},"reference-count":52,"publisher":"Japan Atherosclerosis Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.5551\/jat.64146","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T22:12:21Z","timestamp":1703801541000},"page":"587-602","source":"Crossref","is-referenced-by-count":11,"title":["Remnant Cholesterol is More Strongly Associated with Arterial Stiffness than Traditional Lipids and Lipid Ratios in the General Chinese Population"],"prefix":"10.5551","volume":"31","author":[{"given":"Binqi","family":"Li","sequence":"first","affiliation":[{"name":"School of Medicine, Nankai University"},{"name":"Department of Endocrinology, First medical center of PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Graduate School, Chinese PLA General Hospital"},{"name":"Department of Medical Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital"},{"name":"The Second Medical Center of Chinese PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Eighth Medical Center of PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, First medical center of PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Mu","sequence":"additional","affiliation":[{"name":"School of Medicine, Nankai University"},{"name":"Department of Endocrinology, First medical center of PLA General Hospital"},{"name":"Graduate School, Chinese PLA General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sacco R L, Roth G A, Reddy K S, Arnett D K, Bonita R, Gaziano T A, Heidenreich P A, Huffman M D, Mark B M, Bongani M, Mendis S, Murray C J L, Perel P, Pineiro D J, Smith S C, Taubert K A, Wood D A, Zhao D, Zoghbi W A. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation. Circulation, 2016; 133: e674-e690","DOI":"10.1161\/CIR.0000000000000395"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Iuliia Pavlovska S K, Juraj J, Jana H, Maria S, Irma M R, Juan P G. Associations between high triglycerides and arterial stiffness in a population-based sample: Kardiovize Brno 2030 study. Lipids Health Dis, 2020; 170","DOI":"10.1186\/s12944-020-01345-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Qu G, Zhang Z, Zhu H. Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness. Lipids Health Dis, 2021; 20: 80","DOI":"10.1186\/s12944-021-01509-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993; 362: 801-809","DOI":"10.1038\/362801a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Laurent S, Cockcroft J, Bortel V L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Boudier H S, Wilkinson L. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J, 2006; 27: 2588-2605","DOI":"10.1093\/eurheartj\/ehl254"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Chung T H, Shim J Y, Kwon Y J, Lee Y J. High triglyceride to high\u2010density lipoprotein cholesterol ratio and arterial stiffness in postmenopausal Korean women. J Clin Hypertens, 2019; 21: 399-404","DOI":"10.1111\/jch.13484"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Yamashina A, Tomiyama H, Arai T, Hirose K, Koji Y, Hirayama Y, Yamamoto Y, Hori S. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens Res, 2003; 26: 615-622","DOI":"10.1291\/hypres.26.615"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, Tomiyama H, Yamashina A, Yasuda H, Sawayama T, Ozawa T. Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens, 2009; 27: 2022-2027","DOI":"10.1097\/HJH.0b013e32832e94e7"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yin J, Li M, Yu L, Hu F, Yu Y, Hu L, Bao H, Cheng X. The relationship between the atherogenic index of plasma and arterial stiffness in essential hypertensive patients from China: a cross-sectional study. BMC Cardiovasc Disord, 2021; 21: 245","DOI":"10.1186\/s12872-021-02049-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Gomez-Sanchez L, Garcia-Ortiz L, Patino-Alonso M C, Recio-Rodriguez J I, Fernando R, Marti R,Agudo-Conde C, Rodriguez-Sanchez E, Maderuelo-Fernandez J A, Ramos R, Gomez-Marcos M A. Association of metabolic syndrome and its components with arterial stiffness in Caucasian subjects of the MARK study: a cross-sectional trial. Cardiovasc Diabetol, 2016; 15: 148","DOI":"10.1186\/s12933-016-0465-7"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Wang Z, Li M, Xie J, Gong J, Liu N. Association between remnant cholesterol and arterial stiffness: A secondary analysis based on a cross-sectional study. J Clin Hypertens, 2022; 24: 26-37","DOI":"10.1111\/jch.14384"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Shao Q, Yang Z, Wang Y, Li Q, Han K, Liang J, Shen H, Liu X, Zhou Y, Ma X, Wang Z. Elevated Remnant Cholesterol is Associated with Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome.Journal of atherosclerosis and thrombosis. J Atheroscler Thromb, 2022; 29: 1808-1822","DOI":"10.5551\/jat.63397"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Varbo A, Benn M, Tybjaerg-Hansen A, Nordestgaard BG. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation. Circulation, 2013; 128: 1298-1309","DOI":"10.1161\/CIRCULATIONAHA.113.003008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Sandesara P B, Virani S S, Fazio S, Shapiro M D. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk. Endocr Rev, 2019; 40: 537-557","DOI":"10.1210\/er.2018-00184"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sascau R, Clement A, Radu R, Prisacariu C, St\u0103tescu C. Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review. Nutrients, 2021; 13: 1774","DOI":"10.3390\/nu13061774"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Vallejo-Vaz A J, Fayyad R, Boekholdt S M, Hovingh G K, Kastelein J J, Melamed S, Barter P, Waters D D, Ray K K. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial. Circulation, 2018; 138: 770-781","DOI":"10.1161\/CIRCULATIONAHA.117.032318"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ning G. Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal (REACTION) study. J Diabetes, 2012; 4: 172-173","DOI":"10.1111\/j.1753-0407.2012.00182.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Boekholdt S M, Arsenault B J, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA, 2012; 307: 1302-1309","DOI":"10.1001\/jama.2012.366"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Xue J, Wang Y, Li B,Yu S, Wang A, Wang W, Gao Z, Tang X, Yang L, Wan Q, Qin G, Chen L, Ning G, Mu Y. Triglycerides to high-density lipoprotein cholesterol ratio is superior to triglycerides and other lipid ratios as an indicator of increased urinary albumin-to-creatinine ratio in the general population of China: a cross-sectional study. Lipids Health Dis, 2021; 20: 13","DOI":"10.1186\/s12944-021-01442-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Zhao W, Gong W, Wu N, Li Y, Ye K, Lu B, Zhang Z, Qu S, Li Y, Yang Y, Hu R. Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese. Lipids Health Dis, 2014; 13: 37","DOI":"10.1186\/1476-511X-13-37"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Wu Z, Zhou D, Liu Y, Li Z, Wang J, Han Z, Miao X, Liu X, Li X, Wang W, Guo X, Tao L. Association of TyG index and TG\/HDL-C ratio with arterial stiffness progression in a non-normotensive population. Cardiovasc Diabetol, 2021; 20: 134","DOI":"10.1186\/s12933-021-01330-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Wen J, Zhong Y, Kuang C, Liao J, Chen Z, Yang Q. Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men. J Clin Hypertens, 2017; 19: 771-776","DOI":"10.1111\/jch.13038"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Oram J F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol, 2003; 23: 720-727","DOI":"10.1161\/01.ATV.0000054662.44688.9A"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Zhang YY, Tong XZ, Xia WH, Xie WL, Yu BB, Zhang B, Chen L, Tao J. Increased plasma neopterin levels are associated with reduced endothelial function and arterial elasticity in hypertension. J Hum Hypertens, 2016; 30: 436-441","DOI":"10.1038\/jhh.2015.72"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Lee S, Kim H, Oh B K, Choi H I, Lee J Y, Lee S H, Kim B J, Kim B S, Kang J H, Kang J, Kim S H, Sung K C. Association of inter-arm systolic blood pressure differences with arteriosclerosis and atherosclerosis: A cohort study of 117,407 people. Atherosclerosis, 2022; 342: 19-24","DOI":"10.1016\/j.atherosclerosis.2021.12.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wen J, Huang Y, Lu Y, Yuan H. Associations of non-high-density lipoprotein cholesterol, triglycerides and the total cholesterol\/HDL-c ratio with arterial stiffness independent of low-density lipoprotein cholesterol in a Chinese population. Hypertens Res, 2019; 42: 1223-1230","DOI":"10.1038\/s41440-019-0251-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Association A D. Standards of medical care in diabetes\u20142011. Diabetes Care, 2011; S11-S61","DOI":"10.2337\/dc11-S011"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Dabelea D, Talton J W, D'Agostino R J, Wadwa RP, Urbina EM, Dolan LM, Daniels SR, Marcovina SM, Hamman RF. Cardiovascular risk factors are associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study. Diabetes care, 2013; 36: 3938-3943","DOI":"10.2337\/dc13-0851"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Topouchian J, Labat C, Gautier S, Achimastos A, Blacher J, Cwynar M, Fantin F, Farkas K, Hakobyan Z, Jankowski P, Jelakovic A, Kobalava Z, Konradi A, Kotovskaya Y, Kotsani M, Lazareva I, Litvin A, Milyagin V, Mintale I, Persson O, Ramos R, Rogoza A, Ryliskyte L, Scuteri A, Sirenko Y, Soulis G, Tasic N, Udovychenko M, Urazalina S, Wohlfahrt P, Zelveian P, Benetos A, Asmar R. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens, 2018; 36: 824-833","DOI":"10.1097\/HJH.0000000000001631"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nam S, Kang S, Lee Y, Song SW, Rho JS. Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population. J Diabetes Res, 2015; 2015: 328585","DOI":"10.1155\/2015\/328585"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kilic A, Baydar O, Elcik D, Apayd\u0131n Z, Can MM. Role of dyslipidemia in early vascular aging syndro. Turk J Med Sci, 2021; 51: 727-734","DOI":"10.3906\/sag-2008-165"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Nagayama D, Watanabe Y, Saiki A, Shirai K, Tatsuno I. Lipid Parameters are Independently Associated with Cardio-Ankle Vascular Index (CAVI) in Healthy Japanese Subjects. J Atheroscler Thromb, 2018; 25: 621-633","DOI":"10.5551\/jat.42291"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Zieman S J, Melenovsky V, Kass D A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol, 2005; 25: 932-943","DOI":"10.1161\/01.ATV.0000160548.78317.29"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Hansson G K. Inflammation and Atherosclerosis: The End of a Controversy. Circulation, 2017; 136: 1875-1877","DOI":"10.1161\/CIRCULATIONAHA.117.030484"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes care, 2000; 23: 1766-1769","DOI":"10.2337\/diacare.23.12.1766"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Funada J, Sekiya M, Otani T, Watanabe K, Sato M, Akutsu H. The close relationship between postprandial remnant metabolism and insulin resistance. Atherosclerosis, 2004; 172: 151-154","DOI":"10.1016\/j.atherosclerosis.2003.09.016"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) D A. Cross\u2010linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens, 2003; 1: 3-12","DOI":"10.1097\/00004872-200301000-00002"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Poledne R, Kralova Lesna I, Kralova A, Fronek J, Cejkova S. The relationship between non-HDL cholesterol and macrophage phenotypes in human adipose tissue. J Lipid Res, 2016; 57: 1899-1905","DOI":"10.1194\/jlr.P068015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Tabas I, Bornfeldt K E. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circ Res, 2016; 11: 653-667","DOI":"10.1161\/CIRCRESAHA.115.306256"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Budimir D, Jeroncic A, Gunjaca G, Rudan I, Polasek O, Boban M. Sex-specific association of anthropometric measures of body composition with arterial stiffness in a healthy population. Med Sci Monit, 2012; 18: R65-R71","DOI":"10.12659\/MSM.882457"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) DuPont J J, Kenney R M, Patel A R, Jaffe IZ. Sex differences in mechanisms of arterial stiffness. Br J Pharmacol, 2019; 176: 4208-4225","DOI":"10.1111\/bph.14624"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Gragnano F, Calabro P. Role of dual lipid-lowering therapy in coronary atherosclerosis regression: Evidence from recent studies. Atherosclerosis, 2018; 269: 219-228","DOI":"10.1016\/j.atherosclerosis.2018.01.012"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Mora S, Glynn R J, Boekholdt S M, Nordestgaard B G, Kastelein J P, Ridker P M. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin). J Am Coll Cardiol, 2012; 59: 1521-1528","DOI":"10.1016\/j.yend.2012.05.047"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Havel R J. Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol, 2000,11: 615-620","DOI":"10.1097\/00041433-200012000-00008"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Chi C, Teliewubai J, Lu Y, Fan X, Yu S, Xiong J, Zhou Y, Ji H, Zhang Y, Xu Y. Comparison of various lipid parameters in association of target organ damage: a cohort study. Lipids Health Dis, 2018; 17: 199","DOI":"10.1186\/s12944-018-0800-y"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Harrison S C, Holmes M V, Humphries S E. Mendelian randomisation, lipids, and cardiovascular disease. Lancet, 2012; 380: 543-545","DOI":"10.1016\/S0140-6736(12)60481-4"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Lokki ML, Perola M, Havulinna A, de Faire U, Gigante B, Ingelsson E, Zeller T, Wild P, de Bakker PI, Klungel OH, Maitland-van der Zee AH, Peters BJ, de Boer A, Grobbee DE, Kamphuisen PW, Deneer VH, Elbers CC, Onland-Moret NC, Hofker MH, Wijmenga C, Verschuren WM, Boer JM, van der Schouw YT, Rasheed A, Frossard P, Demissie S, Willer C, Do R, Ordovas JM, Abecasis GR, Boehnke M, Mohlke KL, Daly MJ, Guiducci C, Burtt NP, Surti A, Gonzalez E, Purcell S, Gabriel S, Marrugat J, Peden J, Erdmann J, Diemert P, Willenborg C, K\u00f6nig IR, Fischer M, Hengstenberg C, Ziegler A, Buysschaert I, Lambrechts D, Van de Werf F, Fox KA, El Mokhtari NE, Rubin D, Schrezenmeir J. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet, 2012; 380: 572-580","DOI":"10.1016\/S0140-6736(12)60312-2"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Crosby J, Peloso G M, Auer P L, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang HM, Xue C, Goel A, Farrall M, Duga S, Merlini PA, Asselta R, Girelli D, Olivieri O, Martinelli N, Yin W, Reilly D, Speliotes E, Fox CS, Hveem K, Holmen OL, Nikpay M, Farlow DN, Assimes TL, Franceschini N, Robinson J, North KE, Martin LW, DePristo M, Gupta N, Escher SA, Jansson JH, Van Zuydam N, Palmer CN, Wareham N, Koch W, Meitinger T, Peters A, Lieb W, Erbel R, Konig IR, Kruppa J, Degenhardt F, Gottesman O, Bottinger EP, O'Donnell CJ, Psaty BM, Ballantyne CM, Abecasis G, Ordovas JM, Melander O, Watkins H, Orho-Melander M, Ardissino D, Loos RJ, McPherson R, Willer CJ, Erdmann J, Hall AS, Samani NJ, Deloukas P, Schunkert H, Wilson JG, Kooperberg C, Rich SS, Tracy RP, Lin DY, Altshuler D, Gabriel S, Nickerson DA, Jarvik GP, Cupples LA, Reiner AP, Boerwinkle E, Kathiresan S. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med, 2014; 371: 22-31","DOI":"10.1056\/NEJMoa1307095"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Prenner S B, Mulvey C K, Ferguson J F, Rickels M R, Bhatt A B, Reilly M P. Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis, 2014; 236: 244-250","DOI":"10.1016\/j.atherosclerosis.2014.07.008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Bjornsson E, Thorleifsson G, Helgadottir A, Gu\u00f0nason T, Gu\u00f0bjartsson T, Andersen K, Gr\u00e9tarsd\u00f3ttir S, \u00d3lafsson I, Tragante V, \u00d3lafsson O H, J\u00f3nsd\u00f3ttir B, Eyj\u00f3lfsson G I, Sigur\u00f0ard\u00f3ttir O, Thorgeirsson G, Gu\u00f0bjartsson D F, Thorsteinsd\u00f3ttir U, H\u00f3lm H, Stef\u00e1nsson K. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults. JAMA Cardiol, 2020; 5: 13-20","DOI":"10.1001\/jamacardio.2019.2946"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Chait A, Ginsberg H N, Vaisar T, Heinecke JW, Goldberg IJ, Bornfeldt KE. Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease. Diabetes, 2020; 69: 508-516","DOI":"10.2337\/dbi19-0007"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Fujihara Y, Nakamura T, Horikoshi T, Obata J E, Fujioka D, Watanabe Y, Watanabe K, Kugiyama K. Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels \uff1c70 mg\/dL. Circ J, 2019; 83: 1302-1308","DOI":"10.1253\/circj.CJ-19-0047"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/5\/31_64146\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T04:30:14Z","timestamp":1714797014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/31\/5\/31_64146\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.64146","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,1]]},"article-number":"64146"}}